Reviva Pharmaceuticals Holdings, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $15.9M
Liabilities Breakdown FY2025
Total Liabilities: $7.3M
Asset Breakdown
Total Assets: $15.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $14.4M | 90.7% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $1.5M | 9.3% |
Liabilities Breakdown
Total Liabilities: $7.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.0M | 41.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $4.3M | 58.6% |